| Michael R Liebling, MD | |
|
21840 Normandie Ave, Ste. 700, Torrance, CA 90502-2047 | |
| (310) 222-5101 | |
| (310) 320-5463 |
| Full Name | Michael R Liebling |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Rheumatology |
| Location | 21840 Normandie Ave, Torrance, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386691376 | NPI | - | NPPES |
| 00G283930 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | G28393 (California) | Primary |
| Entity Name | Yellowhawk Tribal Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346283488 PECOS PAC ID: 6608924121 Enrollment ID: O20090511000179 |
News Archive
A statewide tax on the wealthy has significantly boosted mental health programs in California's largest county, helping to reduce homelessness, incarceration and hospitalization, according to a report released Tuesday.
A study carried out by the Institute of Environmental Science and Technology of the Universitat Autònoma de Barcelona and the Instituto de Saúde Pública of the University of Porto, concludes that exposure to natural spaces during the first COVID-19 lockdown in 2020 was beneficial for the mental health of Spanish and Portuguese citizens.
Traumatic brain injury (TBI), a leading cause of death and disability, has become so common in recent times that it has been called a "silent epidemic." And because older adults are more likely to suffer TBI, have worse outcomes, and are less likely to survive their injury than younger adults, older adults are considered a "silent population" within this epidemic.
Omeros Corporation today announced positive results from a Phase 2a clinical trial of OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor, in which the drug was well tolerated and demonstrated comparable systemic pharmacokinetics when administered alone and concomitantly with approved antipsychotic agents in patients with schizophrenia. OMS824 selectively inhibits PDE10, an enzyme expressed in areas of the brain linked to a wide range of diseases that affect cognition, including schizophrenia and Huntington's disease.
In a new study of terminally ill cancer patients, researchers at Dana-Farber Cancer Institute found that those who draw on religion to cope with their illness are more likely to receive intensive, life-prolonging medical care as death approaches –– treatment that often entails a lower quality of life in patients' final days.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael R Liebling, MD 21840 Normandie Ave, Ste. 700, Torrance, CA 90502-2047 Ph: (310) 222-5101 | Michael R Liebling, MD 21840 Normandie Ave, Ste. 700, Torrance, CA 90502-2047 Ph: (310) 222-5101 |
News Archive
A statewide tax on the wealthy has significantly boosted mental health programs in California's largest county, helping to reduce homelessness, incarceration and hospitalization, according to a report released Tuesday.
A study carried out by the Institute of Environmental Science and Technology of the Universitat Autònoma de Barcelona and the Instituto de Saúde Pública of the University of Porto, concludes that exposure to natural spaces during the first COVID-19 lockdown in 2020 was beneficial for the mental health of Spanish and Portuguese citizens.
Traumatic brain injury (TBI), a leading cause of death and disability, has become so common in recent times that it has been called a "silent epidemic." And because older adults are more likely to suffer TBI, have worse outcomes, and are less likely to survive their injury than younger adults, older adults are considered a "silent population" within this epidemic.
Omeros Corporation today announced positive results from a Phase 2a clinical trial of OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor, in which the drug was well tolerated and demonstrated comparable systemic pharmacokinetics when administered alone and concomitantly with approved antipsychotic agents in patients with schizophrenia. OMS824 selectively inhibits PDE10, an enzyme expressed in areas of the brain linked to a wide range of diseases that affect cognition, including schizophrenia and Huntington's disease.
In a new study of terminally ill cancer patients, researchers at Dana-Farber Cancer Institute found that those who draw on religion to cope with their illness are more likely to receive intensive, life-prolonging medical care as death approaches –– treatment that often entails a lower quality of life in patients' final days.
› Verified 9 days ago
Deborah Chon, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3445 Pacific Coast Hwy Ste 100, Torrance, CA 90505 Phone: 310-542-6333 | |
Erika Joyce Kalash, D.O. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3565 Del Amo Blvd, Torrance, CA 90503 Phone: 310-214-0811 | |
Hosayn Khaleeli, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2245 Sepulveda Blvd, Torrance, CA 90501 Phone: 310-320-3204 Fax: 310-320-0919 | |
Mr. Anthony C Dike, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 20280 S Vermont Ave Ste 215, Torrance, CA 90502 Phone: 323-434-4626 Fax: 310-693-8082 | |
Paul J Brown, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3333 Skypark Dr, Torrance, CA 90505 Phone: 310-517-9006 | |
Dr. Philip W Chung, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2841 Lomita Blvd 215, Torrance, CA 90505 Phone: 310-379-2860 Fax: 310-325-1144 | |
Dr. Diane Jennifer Prager, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3445 Pacific Coast Hwy Ste 300, Torrance, CA 90505 Phone: 310-325-8252 |